Evaluation of the Triamcinolone -Acetonide Therapy for the Treatment of the Medial Plica Syndrome

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 28, 2021

Primary Completion Date

September 16, 2024

Study Completion Date

September 30, 2025

Conditions
Medial Plica Syndrome
Interventions
PROCEDURE

Eco-guided Triamcinolone-Acetonide injection

"The treatment consists in injecting 1 ml of Kenacort (corresponding to 40 mg of Triamcinolone Acetonide) diluted in about 1 ml of local anesthetic (Lidocaine) directly into the medial fold of the knee. Through an ultrasound guidance with in plane technique, the flute beak of the needle will be positioned between the two sheets of the synovial fold and the injection will be performed."

Trial Locations (1)

40136

Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER